BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 867 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $236,000 | -3.3% | 2,918 | 0.0% | 0.03% | +18.2% |
Q4 2019 | $244,000 | -7.2% | 2,918 | -3.1% | 0.02% | -15.4% |
Q3 2019 | $263,000 | +9.1% | 3,010 | +2.0% | 0.03% | +8.3% |
Q2 2019 | $241,000 | +0.8% | 2,950 | 0.0% | 0.02% | 0.0% |
Q1 2019 | $239,000 | +5.3% | 2,950 | 0.0% | 0.02% | +9.1% |
Q3 2018 | $227,000 | +5.6% | 2,950 | +1.1% | 0.02% | -4.3% |
Q2 2018 | $215,000 | -77.1% | 2,918 | -78.3% | 0.02% | -83.6% |
Q2 2015 | $940,000 | +1.1% | 13,445 | -1.0% | 0.14% | +4.5% |
Q1 2015 | $930,000 | -14.8% | 13,582 | -8.7% | 0.13% | -17.3% |
Q4 2014 | $1,091,000 | -62.8% | 14,884 | -63.6% | 0.16% | -65.8% |
Q3 2014 | $2,933,000 | -1.7% | 40,859 | -1.0% | 0.47% | -3.1% |
Q2 2014 | $2,983,000 | -18.2% | 41,259 | -16.7% | 0.49% | -18.4% |
Q1 2014 | $3,645,000 | -6.2% | 49,539 | -11.4% | 0.60% | -7.4% |
Q4 2013 | $3,887,000 | +7.5% | 55,892 | +1.5% | 0.65% | -1.2% |
Q3 2013 | $3,616,000 | -3.3% | 55,050 | +2.0% | 0.66% | -6.8% |
Q2 2013 | $3,738,000 | – | 53,966 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |